Fanconi Anemia, Complementation Group L (FANCL) (Middle Region) Peptid
FANCL
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Produktnummer ABIN976692
Kurzübersicht für Fanconi Anemia, Complementation Group L (FANCL) (Middle Region) Peptid (ABIN976692)
Target
FANCL
(Fanconi Anemia, Complementation Group L (FANCL))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-FANCL antibody (Catalog #: ARP56321_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
-
Hintergrund
-
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FAN
Alias Symbols: FAAP43, FLJ10335, PHF9, POG
Protein Interaction Partner: ACVR1,BMPR1B,C17orf70,GGN,HES1,TGFBR1,FANCA,FANCM,YDL160C-A,YOL086W-A
Protein Size: 380 -
Molekulargewicht
- 42 kDa
-
Gen-ID
- 55120
-
NCBI Accession
- NM_001114636, NP_001108108
-
UniProt
- Q9NW38
Target
-
Sie sind hier:
